Medications
Multiple factors cause high prescription drug prices in US
Sticker-shocked patients increasingly wonder why prices for prescription drugs continue to rise in the U.S.
Sep 25, 2015
1
64
News tagged with generic drug
Oncology & Cancer
Antidepressants plus blood thinners cause brain cancer cells to eat themselves in mice
Scientists have been exploring the connection between tricyclic antidepressants and brain cancer since the early 2000s. There's some evidence that the drugs can lower one's risk for developing aggressive glioblastomas, but ...
Sep 24, 2015
0
9122
Medications
Mylan opens $27.14 billion hostile bid for Perrigo
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.
Sep 15, 2015
0
4
Medications
Mylan shareholders approve pursuit of Perrigo
Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon.
Aug 28, 2015
0
5
Medications
FDA lays out proposal for naming lower-cost biotech drugs (Update)
The Food and Drug Administration released its proposal Thursday for naming lower-cost biotech drugs, a critical step in creating a market for the new class of medicines.
Aug 27, 2015
0
5
Medications
A pharmacist explains why drugs cost so much
When a nationally prominent oncologist said "drugs cost too much" during a high-profile speech at the annual meeting of the American Society of Clinical Oncology recently, no one was particularly shocked. The cost of new ...
Aug 10, 2015
0
64
Medications
Mylan gets European clearance in proposed Perrigo takeover
Mylan NV said Wednesday that it received European regulatory approval to move forward with its proposed buyout of Perrigo Co., which has resisted repeated overtures.
Jul 29, 2015
0
8
Medications
Hikma buys US generic drugmaker Roxane for $2.65bn
London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector's latest rapid round of consolidation.
Jul 28, 2015
0
6
Medications
Analysts expect more tie-ups in generic drug business
Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
Jul 27, 2015
0
9
Medications
EU suspends sale of 700 generic drugs made in India
European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU's executive confirmed on Monday.
Jul 27, 2015
0
31
